CIN : U24233KL2007SGC021616
Visitors : 1446454
0471-2945600/46




Notices

Essential Drugs Division

Re-Tender for the supply of Insulin Cartridge and Pen for Mittayi Project– Technical Bid Evaluation–Defects noticed/status–Published

Essential Drugs Division

e-TENDER DOCUMENT FOR THE PROCUREMENT OF RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 500 IU

Essential Drugs Division

e-TENDER DOCUMENT FOR THE PROCUREMENT OF RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 1000 IU

Essential Drugs Division

e-TENDER DOCUMENT FOR THE PROCUREMENT OF RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 1500 IU

Essential Drugs Division

e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

e-tender for the procurement Veterinary Medicines for Animal Husbandry department for the year 2024-25 - ANNEXURES WORD DOCUMENT

Essential Drugs Division

KMSCL- e- tender for the Procurement of Veterinary Medicines to the Animal Husbandry Department For the year 2024-25

Essential Drugs Division

Technical Bid Evaluation for E-tender for the Procurement of Insecticides for NVBDCP & Plan fund for 2023-24 & 2024-25

Essential Drugs Division

KMSCL- Re-tender for the Procurement of Anti- cancer Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg

Essential Drugs Division

KMSCL- Re-tender for the Procurement of Speciality Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg

Essential Drugs Division

KMSCL- Re-tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg

Essential Drugs Division

Re-tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg

Essential Drugs Division

Re-tender for the Procurement of Drugs for the year 2024-25– Price Bid Evaluation – Final Bid Status– Published

Essential Drugs Division

e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation–Published

Essential Drugs Division

Re-tender for the procurement of De-Addiction drugs for the year 2024-25

Essential Drugs Division

Re-tender for the procurement of De-Addiction drugs for the year 2024-25

Essential Drugs Division

Final Bid ranking status of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis AS 5%(BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24

Essential Drugs Division

FOR THE PROCUREMENT OF TEST KITS FOR NVBDCP and PLAN FUND

Essential Drugs Division

FOR THE PROCUREMENT OF TEST KITS FOR NVBDCP and PLAN FUND

Essential Drugs Division

Re-tender for the supply of Insulin Cartridge and Pen for the year 2024-25

Essential Drugs Division

Re-tender for the Procurement of Drugs/Supplies(Category III-VIII) for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

Re-tender for the procurement of IFA SYRUP for Anemia Mukth Bharat for the year 2023-2024

Essential Drugs Division

Re-tender for the procurement of IFA SYRUP for Anemia Mukth Bharat for the year 2023-2024

Essential Drugs Division

Re-tender for the procurement of IFA SYRUP for Anemia Mukth Bharat for the year 2023-2024

Essential Drugs Division

List of Selected bidders for Price Bid Opening of E-TENDER for the supply of Insulin Cartridge and Pen for Mittayi Project

Essential Drugs Division

KMSCL – Re-tender for the Procurement of Drugs/ Supplies for the year for the year 2024-25 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation–Published

Essential Drugs Division

Provisional Bid ranking status of Price bid evaluation of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24

Essential Drugs Division

Provisional Bid ranking status of Price bid evaluation of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24

Essential Drugs Division

Re-tender for the Procurement of Drugs of NVHCP for the year 2024-25

Essential Drugs Division

"KMSCL –e-Tender for the procurement of drugs and Growth Hormone for the treatment of Rare Disease under NPRD scheme for the year 2024-25 – Amendment Notice – Published –reg

Essential Drugs Division

e-Tender for the procurement of drugs and Growth Hormone for the treatment of Rare Disease under NPRD scheme for the year 2024-25 – Time Extension Notice – Published –reg

Essential Drugs Division

Re-tender for the procurement of Anticancer drugs for the year 2024-25

Essential Drugs Division

Re-tender for the Procurement of Anti-Cancer Drugs for the year 2024-25 – Technical Bid Evaluation-List of selected/rejected bidders/products for price bid evaluation – Published

Essential Drugs Division

E-tender No. KMSCL/ED/RD-SAT/RC/2024/019 dated 13.09.2024 invited for the procurement of drugs for Rare Disease and Growth Hormone under NPRD Scheme

Essential Drugs Division

KMSCL- Re-tender for the Procurement of Drugs /Supplies for the year 2024- 25- Technical Bid Evaluation- Defects Noticed/Status- Publised -reg

Essential Drugs Division

KMSCL- E-Tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24-n Price bid evaluation - Final Bid ranking status - Published - reg

Essential Drugs Division

Re-tender for the procurement of Anti Cancer Drugs for the year 2024-25 - Technical Bid Evaluation - Defects noticed/status- Published

Essential Drugs Division

KMSCL Re-tender for the Procurement of Drugs for the year 2024-25–Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status–Published–reg

Essential Drugs Division

KMSCL Re-tender for the Procurement of SpecialityDrugs for the year 2024-25–Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status–Published–reg

Essential Drugs Division

Notice on Final Bid status against the e-tender for the Procurement of Drugs for De- Addiction Centres for the year 2024-25

Essential Drugs Division

E-TENDER DOCUMENT FOR THE PROCUREMENT OF INSECTICIDES For NVBDCP & PLAN SCHEME for the year 2023-24 & 2024-25

Essential Drugs Division

Provisional Bid ranking status of Price bid evaluation against e-tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24

Essential Drugs Division

List of selected/ rejected bidders/products for price bid evaluation against Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24

Essential Drugs Division

KMSCL -E-tender for the Procurement of Veterinary Medicines for the year 2023-24-Price Bid Evaluation- Final Bid status -Published-reg: vide tender no:- KMSCL/AHD-VET/RC/2024/004; Dated 08.04.2024

Essential Drugs Division

List of selected/ rejected bidders/products for price bid evaluation against E- Tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24 vide e-tender No-KMSCL/ED/IFA/RC/2024/009 dtd. 04.06.2024

Essential Drugs Division

E-TENDER for the supply of Insulin Cartridge and Pen for Mittayi Project -vide tender No- E-tender No.KMSCL/ED/ /MITTAYI/ RC/2024/010 DTD.11-06-2024.

Essential Drugs Division

Procurement of Drugs for De-Addiction Centres for the year 2024-25 vide e-tender No- KMSCL/ED/De-Addiction/RC/2024/008 DATED 29.05.2024

Essential Drugs Division

KMSCL-Re-tender for the procurement of Drugs for the year 2024-25- Technical Bid Evaluation- List of selected/rejected bidders/ products for price evaluation- Published- reg.

Essential Drugs Division

KMSCL- Re-tender for the procurement of Specialty Drugs for the year 2024-25- Technical Bid Evaluation- Defects noticed and status- Published- reg

Essential Drugs Division

Technical Bid Evaluation of Re-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for Surveillance and Control of Communicable Disease Scheme & NVBDCP for the year 2023-24

Essential Drugs Division

Final Bid ranking status of E- Tender for the Procurement of Drugs for NVHCP for the year 2024-25 vide

Essential Drugs Division

Provisional Bid ranking status of e tender for the Procurement of Drugs for NVHCP for the year 2024-25

Essential Drugs Division

List of Selected bidders for Price Bid Opening of tender for the Procurement of Drugs for De-Addiction Centres for the year 2024-25

Essential Drugs Division

Re-tender for the procurement of drugs/supplies for the year 2024-25"vide Re-tender No. KMSCL/ED/III - VIII/RT/2024/016

Essential Drugs Division

KMSCL - E-tender for the Procurement of Drugs/ Supplies (Category III - VIII) for the year 2024-25 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published

Essential Drugs Division

List of selected/ rejected bidders for Price bid evaluation against the tender for the Procurement of Drugs for NVHCP for the year 2024-25

Essential Drugs Division

KMSCL- Re- tender for the Procurement of Drugs for the year 2024-25- Technical Bid Evaluation - defects noticed/ status- Published- reg

Essential Drugs Division

KMSCL- Re- tender for the Procurement of Specialty Drugs for the year 2024-25- Technical Bid Evaluation - defects noticed and status- Published- reg

Essential Drugs Division

Drug Licence Details of KMSCL Warehouses

Essential Drugs Division

Notice on Technical Bid Evaluaiton of tender for the Procurement of Drugs for Anaemia Mukth Bharat for the year 2023-24

Essential Drugs Division

E- Tender for the Procurement of Drugs for NVHCP for the year 2024-25

Essential Drugs Division

E- Tender for the Procurement of Drugs for De-Addiction Centers for the year 2024-25

Essential Drugs Division

KMSCL- E-tender for the Procurement of Veterinary Medicines for the year 2023-24- Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status - Published- reg

Essential Drugs Division

Re-Tender for the procurement ANTI CANCER DRUGS for the year 2024-25

Essential Drugs Division

Final Bid Ranking Status of e-tender for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024-25

Essential Drugs Division

KMSCL-E- tender for the Procurement of Veterinary Medicines for the year 2023-24-Technical bid Evaluation- List of selected/rejected bidders products for price bid evaluation - Published -reg

Essential Drugs Division

E-tender for the Procurement of Recombinant Anti Haemophilic Factor VIII 1000 IU & 1500 IU for the year 2023-24- Price Bid Evaluation - Final Bid Status- Published - reg

Essential Drugs Division

KMSCL- E-tender for the procurement of Anti Cancer Drugs for the year 2024-25- Price Bid Evaluation - Items Deferred- Final Bid Status- Published - Reg

Essential Drugs Division

KMSCL- E-tender for the procurement of Drugs/Supplies (Category III-VIII) for the year 2024-25- Price Bid Evaluation - Final Bid Status- published- reg

Essential Drugs Division

KMSCL-E- Tender for the procurement of Anti Retroviral Drugs for KSACS for the year 2024-25 - Price bid evaluation - Provisional Bid Ranking Status- Published- reg

Essential Drugs Division

Final Bid ranking Status Published for the Procurement of Vitamin A Oral Solution IP for the year 2023-24

Essential Drugs Division

List of selected/ rejected bidders for Price bid evaluation for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024-25

Essential Drugs Division

KMSCL- Re-tender for the Procurement of BIOLARVICIDE:BACILLUS THURINGIENSIS ISRAELIENSIS (BTI) For NVBDCP for the year 2023-24.

Essential Drugs Division

KMSCL- e- tender Document for the procurement of Veterinary Medicines for the year 2023-24 Technical Bid Evaluation - Defects noticed/ status - Published - reg

Essential Drugs Division

e-tender for the Procurement of Drugs/ Supplies (Category III - VIII) for the year 2024-25 - Supplier wise rate quoted and Provisional bid status - Publishing

Essential Drugs Division

KMSCL- E-Tender for the Procurement of Anti Retroviral Drugs for KSACS for the year 2024 - 25- Technical Bid Evaluation - Defects noticed/ status - Published

Essential Drugs Division

"Re-tender for the procurement of Specialty Drugs for the year 2024-25

Essential Drugs Division

Re-tender for the procurement of Drugs for the year 2024-25

Essential Drugs Division

E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Corrigendum published

Essential Drugs Division

E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Published

Essential Drugs Division

E-tender for the Procurement of Drugs/ Supplies for the year 2024-25 - Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation – Published

Essential Drugs Division

Cancellation of tender -e-tender for the procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 -5% AS for NVBDCP for the year 2023-24

Essential Drugs Division

Notice on Provisional Bid ranking status of E- Tender for the Procurement of Vitamin A Oral Solution IP for the year 2023-24

Essential Drugs Division

e- Tender for the Procurement of Drugs for Anemia Mukt Bharat for the year 2023-24

Essential Drugs Division

E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Price Bid Evaluation – Final Bid Status– Published

Essential Drugs Division

e-tender for the Procurement of Drugs for De- Addiction Centers for the year 2024-25

Essential Drugs Division

e- Tender for the procurement of Drugs For NVHCP for the year 2024-25

Essential Drugs Division

List of selected/ rejected bidders for Price bid evaluation of Tender for the Procurement of Vitamin A Paediatric Oral Solution IP for the year 2023-24

Essential Drugs Division

E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

e-tender for the procurement of drugs/supplies for the year 2024-25 - Technical bid evaluation -Defects noticed/status- Published

Essential Drugs Division

KMSCL- e- tender for the Procurement of Drugs for the year 2024- 25- Price Bid Evaluation - Items Deferred - Final Bid Status - Published- reg

Essential Drugs Division

KMSCL- E-tender for the Procurement of Speciality Drugs for the year 2024-25- Price Bid EValuation- items Deferred - Final Bid Status- Published- reg

Essential Drugs Division

KMSCL-E-tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation- Final Bid Status- Published- reg

Essential Drugs Division

e -tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status- Publised- reg

Essential Drugs Division

E-tender for the Procurement of Specialty Drugs for the year 2024-25 – Price Bid Evaluation – Final Bid Status– Published

Essential Drugs Division

Provisional Bid ranking status of Re-tender for the Procurement of Insecticides for NVBDCP & Plan fund for the year 2022-23 vide e-tender No- KMSCL/ED/INS-NVBDCP & PLAN/RC/2023/012 Dated 26.07.2023

Essential Drugs Division

e-tender for the procurement of drugs for the year 2024-25 - Notice on Technical Bid evaluation- Defects noticed/status - Amendment - Published